News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why Abbott Laboratories (ABT)'s Stake In Mylan Inc. (MYL) Will Be Value-Creative


7/21/2014 9:20:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Abbott (NYSE:ABT) has a track record that is unrivaled. The firm is more than 125 years old and remains aligned with favorable long-term healthcare trends in both developed and developing markets. We believe Abbott's nutritionals segment is one of the most attractive businesses in all of the healthcare space, boasting such brand names as EAS, Myoplex, and ZonePerfect. Let's take a look at the firm's second-quarter results, which it reported Wednesday.

Help employers find you! Check out all the jobs and post your resume.

Read at Seeking Alpha


comments powered by Disqus
Mylan Inc.
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES